StockTipsArenaBeta

BUY Ajanta Pharma Limited — Prabhudas Lilladher

BUYAjanta Pharma Limited
Ajanta Pharma share price target & all analyst calls

byPrabhudas LilladherHorizon: NA (inferred 1 year)31 Jul 2026via Moneycontrol Broker Research

Entry₹3,465.2Inferred
Target₹3,730
Total upside +7.64% (call closed)
Stop lossNot given
Exit₹3,73017 Aug 2026, 12:08 pm
Target hit+7.64%0.00%upside left
Follow Prabhudas Lilladher for new calls(70% target hit, 407 closed calls)Get alertsWatch AJANTPHARM for new buy/sell callsGet alertsSee 3 active Long-term calls on AJANTPHARMSee 274 active Long-term picks this week

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.

Frozen at close · 17 Aug 2026
7 supporting2 neutral4 opposing
Supports the BUY call (7)

Ajanta Pharma Shares Rise 2% as Q1 Profit Reaches Rs 334 Crore

NewsGoogle News·14 Aug · 3d ago

(opens in new tab)

3 other SEBI-registered advisors have active long-term BUY calls on this stock, with 1 issued in the last 14 days

Advisor consensus · same horizon·10 Aug · 1w ago

Dividend Alert: Ajanta Pharma Announces Interim Dividend — Check Record Date, Payout Date

NewsNdtv-Profit·30 Jul · 2w ago

(opens in new tab)

Ajanta Pharma Q1 profit jumps 31% on strong US sales; declares ₹32 dividend

NewsCnbc-Tv18·30 Jul · 2w ago

(opens in new tab)

Q1 Results Today Highlights: Swiggy narrows loss, Bajaj Finance, M&M, Gillette, Vedanta, Vedanta Aluminium, Ajanta Pharma, IRFC, ICRA, Niva Bupa profit rise, Hyundai PAT down; Torrent Pharma PAT up 3.3%; Tata Steel profit jumps 19%, NSDL's PAT up 9%

NewsHbl·30 Jul · 3w ago

(opens in new tab)
Neutral / worth noting (2)

Ajanta Pharma Limited has submitted to the Exchange, the financial results for the period ended Jun 30, 2026.

NSE · Outcome of Board Meeting·30 Jul · 2w ago

(opens in new tab)
Weighs against the BUY call (4)

Ajanta Pharma షేర్ ధర పడిపోయింది.. కారణం ఇదే!

NewsGoogle News·5 Aug · 2w ago

(opens in new tab)

Ajanta Pharma Share: डिविडेंड रिकॉर्ड डेट पर **3%** गिरा शेयर, जानिए क्या है वजह

NewsGoogle News·5 Aug · 2w ago

(opens in new tab)

Ajanta Pharma Share Price: डिव्हिडंडमुळे शेअर पडला 3%, पण ही आहे खरी बातमी!

NewsGoogle News·5 Aug · 2w ago

(opens in new tab)

Trump's tariff policy: Abbott India, Ajanta Pharma to Alembic — pharma stocks crash up to 4%

NewsLivemint·24 Jul · 3w ago

(opens in new tab)

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.

Other calls on Ajanta Pharma

All analyst calls on Ajanta Pharma

More from Prabhudas Lilladher

Every call and its outcome